StonvexLoading…
StonvexStonvexStonvexCore line items from PCYO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-08-31 | Annual 2024 2024-08-31 | Annual 2023 2023-08-31 | Annual 2022 2022-08-31 |
|---|---|---|---|---|
Revenue | $26.09M | $28.75M | $14.59M | $23.00M |
Operating Income | $7.67M | $12.24M | $2.07M | $10.10M |
Net Income | $13.11M | $11.61M | $4.70M | $9.62M |
EPS (Diluted) | $0.54 | $0.48 | $0.19 | $0.40 |
Total Assets | $162.28M | $147.35M | $133.22M | $129.23M |
Total Liabilities | $19.54M | $17.65M | $14.98M | $16.23M |
Cash & Equivalents | $21.93M | $22.11M | $26.01M | $34.89M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 24.07M | 24.06M | 24.08M | 23.98M |